Annual D&A
$265.00 K
-$20.00 K-7.02%
December 31, 2023
Summary
- As of February 8, 2025, BCLI annual depreciation & amortization is $265.00 thousand, with the most recent change of -$20.00 thousand (-7.02%) on December 31, 2023.
- During the last 3 years, BCLI annual D&A has risen by +$46.00 thousand (+21.00%).
- BCLI annual D&A is now -87.48% below its all-time high of $2.12 million, reached on December 31, 2006.
Performance
BCLI Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$59.00 K
-$5000.00-7.81%
September 30, 2024
Summary
- As of February 8, 2025, BCLI quarterly depreciation & amortization is $59.00 thousand, with the most recent change of -$5000.00 (-7.81%) on September 30, 2024.
- Over the past year, BCLI quarterly D&A has dropped by -$5000.00 (-7.81%).
- BCLI quarterly D&A is now -93.06% below its all-time high of $849.60 thousand, reached on December 31, 2005.
Performance
BCLI Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$253.00 K
-$6000.00-2.32%
September 30, 2024
Summary
- As of February 8, 2025, BCLI TTM depreciation & amortization is $253.00 thousand, with the most recent change of -$6000.00 (-2.32%) on September 30, 2024.
- Over the past year, BCLI TTM D&A has dropped by -$6000.00 (-2.32%).
- BCLI TTM D&A is now -88.15% below its all-time high of $2.13 million, reached on September 30, 2006.
Performance
BCLI TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
BCLI Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.0% | -7.8% | -2.3% |
| 3 y3 years | +21.0% | -7.8% | -2.3% |
| 5 y5 years | +140.9% | -7.8% | -2.3% |
BCLI Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7.0% | +1.9% | -20.3% | at low | -11.2% | at low |
| 5 y | 5-year | -7.0% | +61.6% | -20.3% | +20.4% | -11.2% | +54.3% |
| alltime | all time | -87.5% | >+9999.0% | -93.1% | +103.7% | -88.2% | +115.8% |
Brainstorm Cell Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $59.00 K(-7.8%) | $253.00 K(-2.3%) |
| Jun 2024 | - | $64.00 K(0.0%) | $259.00 K(-1.1%) |
| Mar 2024 | - | $64.00 K(-3.0%) | $262.00 K(-1.1%) |
| Dec 2023 | $265.00 K(-7.0%) | $66.00 K(+1.5%) | $265.00 K(-1.5%) |
| Sep 2023 | - | $65.00 K(-3.0%) | $269.00 K(-1.8%) |
| Jun 2023 | - | $67.00 K(0.0%) | $274.00 K(-1.4%) |
| Mar 2023 | - | $67.00 K(-4.3%) | $278.00 K(-2.5%) |
| Dec 2022 | $285.00 K(+9.6%) | $70.00 K(0.0%) | $285.00 K(0.0%) |
| Sep 2022 | - | $70.00 K(-1.4%) | $285.00 K(+1.1%) |
| Jun 2022 | - | $71.00 K(-4.1%) | $282.00 K(+3.3%) |
| Mar 2022 | - | $74.00 K(+5.7%) | $273.00 K(+5.0%) |
| Dec 2021 | $260.00 K(+18.7%) | $70.00 K(+4.5%) | $260.00 K(+2.4%) |
| Sep 2021 | - | $67.00 K(+8.1%) | $254.00 K(+4.5%) |
| Jun 2021 | - | $62.00 K(+1.6%) | $243.00 K(+5.2%) |
| Mar 2021 | - | $61.00 K(-4.7%) | $231.00 K(+5.5%) |
| Dec 2020 | $219.00 K(+33.5%) | $64.00 K(+14.3%) | $219.00 K(+6.8%) |
| Sep 2020 | - | $56.00 K(+12.0%) | $205.00 K(+10.2%) |
| Jun 2020 | - | $50.00 K(+2.0%) | $186.00 K(+10.1%) |
| Mar 2020 | - | $49.00 K(-2.0%) | $169.00 K(+3.0%) |
| Dec 2019 | $164.00 K(+49.1%) | $50.00 K(+35.1%) | $164.00 K(+21.5%) |
| Sep 2019 | - | $37.00 K(+12.1%) | $135.00 K(+3.1%) |
| Jun 2019 | - | $33.00 K(-25.0%) | $131.00 K(+1.6%) |
| Mar 2019 | - | $44.00 K(+109.5%) | $129.00 K(+17.3%) |
| Dec 2018 | $110.00 K(+29.4%) | $21.00 K(-36.4%) | $110.00 K(-6.0%) |
| Sep 2018 | - | $33.00 K(+6.5%) | $117.00 K(+9.3%) |
| Jun 2018 | - | $31.00 K(+24.0%) | $107.00 K(+13.8%) |
| Mar 2018 | - | $25.00 K(-10.7%) | $94.00 K(+10.6%) |
| Dec 2017 | $85.00 K(+10.4%) | $28.00 K(+21.7%) | $85.00 K(+7.6%) |
| Sep 2017 | - | $23.00 K(+27.8%) | $79.00 K(+8.2%) |
| Jun 2017 | - | $18.00 K(+12.5%) | $73.00 K(-5.2%) |
| Mar 2017 | - | $16.00 K(-27.3%) | $77.00 K(0.0%) |
| Dec 2016 | $77.00 K | $22.00 K(+29.4%) | $77.00 K(+11.6%) |
| Sep 2016 | - | $17.00 K(-22.7%) | $69.00 K(-11.5%) |
| Jun 2016 | - | $22.00 K(+37.5%) | $78.00 K(-24.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $16.00 K(+14.3%) | $103.00 K(+18.4%) |
| Dec 2015 | $87.00 K(-46.3%) | $14.00 K(-46.2%) | $87.00 K(+19.2%) |
| Sep 2015 | - | $26.00 K(-44.7%) | $73.00 K(+55.3%) |
| Jun 2015 | - | $47.00 K(-140.5%) | $47.00 K(>+9900.0%) |
| Dec 2011 | - | -$116.00 K(-390.0%) | $0.00(-100.0%) |
| Sep 2011 | - | $40.00 K(+5.3%) | $152.00 K(-1.3%) |
| Jun 2011 | - | $38.00 K(0.0%) | $154.00 K(-23.0%) |
| Mar 2011 | - | $38.00 K(+5.6%) | $200.00 K(+23.5%) |
| Dec 2010 | $162.00 K(-3.6%) | $36.00 K(-14.3%) | $162.00 K(+28.6%) |
| Sep 2010 | - | $42.00 K(-50.0%) | $126.00 K(+50.0%) |
| Jun 2010 | - | $84.00 K(-44.4%) | $84.00 K(-44.4%) |
| Dec 2009 | $168.00 K(+11.3%) | - | - |
| Dec 2008 | $151.00 K(-6.2%) | $151.00 K(-132.5%) | $151.00 K(-109.4%) |
| Sep 2008 | - | -$464.00 K(-336.7%) | -$1.60 M(+221.0%) |
| Jun 2008 | - | $196.00 K(-26.9%) | -$500.00 K(+144.0%) |
| Mar 2008 | - | $268.00 K(-116.7%) | -$204.90 K(-227.3%) |
| Dec 2007 | $161.00 K(-92.4%) | -$1.60 M(-350.4%) | $161.00 K(-90.9%) |
| Sep 2007 | - | $641.00 K(+30.5%) | $1.77 M(+10.9%) |
| Jun 2007 | - | $491.10 K(-22.5%) | $1.59 M(+5.5%) |
| Mar 2007 | - | $633.90 K(+35.6%) | $1.51 M(-29.3%) |
| Dec 2006 | $2.12 M(+65.1%) | - | - |
| Sep 2006 | - | $467.40 K(+14.4%) | $2.13 M(+45.3%) |
| Jun 2006 | - | $408.60 K(0.0%) | $1.47 M(+14.6%) |
| Mar 2006 | - | $408.60 K(-51.9%) | $1.28 M(+0.5%) |
| Mar 2006 | $1.28 M(+119.4%) | - | - |
| Dec 2005 | - | $849.60 K(-529.5%) | $1.27 M(+109.8%) |
| Sep 2005 | - | -$197.80 K(-189.4%) | $607.70 K(-24.6%) |
| Jun 2005 | - | $221.30 K(-44.9%) | $805.50 K(+37.9%) |
| Mar 2005 | $584.30 K(>+9900.0%) | $401.70 K(+120.1%) | $584.20 K(+219.8%) |
| Dec 2004 | - | $182.50 K(>+9900.0%) | $182.70 K(>+9900.0%) |
| Mar 2004 | $200.00(-99.1%) | $200.00(-101.7%) | $100.00(-200.0%) |
| Dec 2003 | - | -$11.50 K(-294.9%) | -$100.00(-100.9%) |
| Sep 2003 | - | $5900.00(+7.3%) | $11.40 K(+107.3%) |
| Jun 2003 | - | $5500.00 | $5500.00 |
| Mar 2003 | $21.60 K | - | - |
FAQ
- What is Brainstorm Cell Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics annual D&A year-on-year change?
- What is Brainstorm Cell Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics quarterly D&A year-on-year change?
- What is Brainstorm Cell Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics TTM D&A year-on-year change?
What is Brainstorm Cell Therapeutics annual depreciation & amortization?
The current annual D&A of BCLI is $265.00 K
What is the all time high annual D&A for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high annual depreciation & amortization is $2.12 M
What is Brainstorm Cell Therapeutics annual D&A year-on-year change?
Over the past year, BCLI annual depreciation & amortization has changed by -$20.00 K (-7.02%)
What is Brainstorm Cell Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of BCLI is $59.00 K
What is the all time high quarterly D&A for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high quarterly depreciation & amortization is $849.60 K
What is Brainstorm Cell Therapeutics quarterly D&A year-on-year change?
Over the past year, BCLI quarterly depreciation & amortization has changed by -$5000.00 (-7.81%)
What is Brainstorm Cell Therapeutics TTM depreciation & amortization?
The current TTM D&A of BCLI is $253.00 K
What is the all time high TTM D&A for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high TTM depreciation & amortization is $2.13 M
What is Brainstorm Cell Therapeutics TTM D&A year-on-year change?
Over the past year, BCLI TTM depreciation & amortization has changed by -$6000.00 (-2.32%)